Product
VSV-ZEBOV
1 clinical trial
1 indication
Indication
Ebola virus diseaseClinical trial
A Phase I/II Dose-finding Randomized, Single-center, Double-blind, Placebo-controlled Safety and Immunogenicity Trial of the Vesicular Stomatitis Virus-vectored Zaire Ebola Candidate Vaccine BPSC1001 (VSVΔG-ZEBOV) in Healthy Adults.Status: Completed, Estimated PCD: 2015-04-01